News from inspiremd, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 01, 2015, 08:00 ET

InspireMD to Present at the Rodman & Renshaw 17th Annual Global Investment Conference

 InspireMD, Inc. (NYSE MKT: NSPR) a leader in stent embolic prevention systems ("EPS") and thrombus management technologies, today announced...

Aug 05, 2015, 16:10 ET

InspireMD Reports Financial Results for the Second Quarter Ended June 30, 2015

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic prevention systems ("EPS"), today announced its...

Aug 05, 2015, 16:05 ET

InspireMD Announces Distribution Partnership of its CGuard™ Embolic Prevention System with Penumbra, Inc.

InspireMD, Inc. (NYSE MKT: NSPR) a leader in stent embolic prevention systems ("EPS") and thrombus management technologies, today announced that it...

Jul 14, 2015, 08:00 ET

InspireMD to Report Financial Results for the Second Quarter Ended June 30, 2015 on Wednesday, August 5th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, announced today that it will release...

Jul 07, 2015, 08:00 ET

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that...

May 22, 2015, 08:00 ET

InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced that...

May 12, 2015, 08:00 ET

InspireMD Announces Clinical Presentations on CGuard and MGuard Systems with MicroNet™ Technology at EuroPCR 2015 Conference

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced that there...

May 11, 2015, 08:00 ET

InspireMD Reports Financial Results for the First Quarter Ended March 31, 2015

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced its...

May 05, 2015, 16:05 ET

InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, announced today that it will release...

Apr 27, 2015, 08:13 ET

InspireMD Announces MGuard™ Prime Approval in Brazil

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced it...

Apr 15, 2015, 08:00 ET

InspireMD Announces Completion of Sales Restructuring Program

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced the...

Mar 16, 2015, 09:00 ET

InspireMD Plan of Compliance Accepted by NYSE MKT

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"),  announced today that...

Mar 12, 2015, 16:05 ET

InspireMD Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2014

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in stent embolic protection systems ("EPS"), today announced its...

Mar 09, 2015, 16:52 ET

InspireMD Announces Closing of Public Offering for Approximately $13.7 Million

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems ("EPS"), today announced the...

Mar 06, 2015, 11:30 ET

InspireMD to Report Financial Results for the Fourth Quarter and Year Ended December 31, 2014 on Thursday, March 12th

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems, announced today that it will...

Mar 04, 2015, 07:52 ET

InspireMD Announces Public Offering for Approximately $13.5 Million

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems ("EPS"), today announced that...

Mar 03, 2015, 16:15 ET

InspireMD Announces Proposed Public Offering of Common Stock and Warrants

 InspireMD, Inc. ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in embolic protection systems ("EPS"), today announced that it...

Feb 26, 2015, 16:30 ET

InspireMD to Present at the Cowen and Company 35th Annual Healthcare Conference

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that its...

Jan 27, 2015, 08:30 ET

InspireMD Receives CE Mark Approval for Its New CGuard RX and Announces Positive Six Month Follow-Up CARENET Trial Data at LINC 2015

InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced that it received...

Jan 21, 2015, 16:05 ET

InspireMD Announces Notification of NYSE MKT Listing Deficiency

 InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic protection systems ("EPS"), today announced the receipt...